$ZS
Zscaler, Inc. Stock $zs

$zs Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000171368324000150 Filed on December 05, 2024

Income Statement

Concept	2024 Q4
Revenue	$628.0M
YoY Change	26.42%
Cost Of Revenue	$141.5M
YoY Change	26.99%
Gross Profit	$486.5M
YoY Change	26.26%
Gross Profit Margin	77.47%
Selling, General & Admin	$362.9M
YoY Change	14.18%
% of Gross Profit	74.6%
Research & Development	$154.3M
YoY Change	35.86%
% of Gross Profit	31.71%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$517.2M
YoY Change	19.89%
Operating Profit	-$30.67M
YoY Change	-33.42%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$652.0K
YoY Change	-46.2%
Pretax Income	-$4.414M
YoY Change	-81.97%
Income Tax	$7.600M
% Of Pretax Income
Net Earnings	-$12.05M
YoY Change	-64.01%
Net Earnings / Revenue	-1.92%
Basic Earnings Per Share	-$0.08
Diluted Earnings Per Share	-$0.08
COMMON SHARES
Basic Shares Outstanding	152.6M shares
Diluted Shares Outstanding	152.6M shares

Balance Sheet

Concept	2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.554B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$424.6M
Other Receivables
Total Short-Term Assets	$3.394B
YoY Change	17.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$409.0M
YoY Change	54.0%
Goodwill	$417.0M
YoY Change	351.23%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$58.85M
YoY Change	97.2%
Total Long-Term Assets	$1.315B
YoY Change	76.78%
TOTAL ASSETS
Total Short-Term Assets	$3.394B
Total Long-Term Assets	$1.315B
Total Assets	$4.709B
YoY Change	29.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.37M
YoY Change	9.18%
Accrued Expenses
YoY Change
Deferred Revenue	$1.533B
YoY Change	23.19%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.964B
YoY Change	101.0%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities	$24.27M
YoY Change	15.61%
Total Long-Term Liabilities	$24.27M
YoY Change	15.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.964B
Total Long-Term Liabilities	$24.27M
Total Liabilities	$3.280B
YoY Change	16.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.160B
YoY Change	3.23%
Common Stock	$153.0K
YoY Change	3.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.429B
YoY Change
Total Liabilities & Shareholders Equity	$4.709B
YoY Change	29.53%

Cashflow Statement

Concept	2024 Q4
OPERATING ACTIVITIES
Net Income	-$12.05M
YoY Change	-64.01%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$331.3M
YoY Change	27.04%
INVESTING ACTIVITIES
Capital Expenditures	$17.03M
YoY Change	-40.59%
Acquisitions	$0.00
YoY Change	-100.0%
Other Investing Activities
YoY Change
Cash From Investing Activities	-$201.7M
YoY Change	24.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$890.0K
YoY Change	-29.14%
NET CHANGE
Cash From Operating Activities	$331.3M
Cash From Investing Activities	-$201.7M
Cash From Financing Activities	$890.0K
Net Change In Cash	$130.6M
YoY Change	31.2%
FREE CASH FLOW
Cash From Operating Activities	$331.3M
Capital Expenditures	$17.03M
Free Cash Flow	$314.3M
YoY Change	35.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
CY2024Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	us-gaap	Net Income Loss NetIncomeLoss	-12051000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-33483000	usd
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q3	zs	Cash Equivalents And Short Term Investments Estimated Fair Value CashEquivalentsAndShortTermInvestmentsEstimatedFairValue	2260168000	usd
CY2024Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1421768000	usd
CY2024Q4	zs	Cash Equivalents Gross Unrealized Gains CashEquivalentsGrossUnrealizedGains	8000	usd
CY2024Q4	zs	Cash Equivalents Gross Unrealized Losses CashEquivalentsGrossUnrealizedLosses	19000	usd
CY2024Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1421757000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	1153651000	usd
CY2024Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2315000	usd
CY2024Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1714000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	1154252000	usd
CY2024Q4	zs	Cash Equivalents And Available For Sale Securities At Cost CashEquivalentsAndAvailableForSaleSecuritiesAtCost	2575419000	usd
CY2024Q4	zs	Cash Equivalents And Short Term Investments Gross Unrealized Gains CashEquivalentsAndShortTermInvestmentsGrossUnrealizedGains	2323000	usd
CY2024Q4	zs	Cash Equivalents And Short Term Investments Gross Unrealized Losses CashEquivalentsAndShortTermInvestmentsGrossUnrealizedLosses	1733000	usd
CY2024Q4	zs	Cash Equivalents And Short Term Investments Estimated Fair Value CashEquivalentsAndShortTermInvestmentsEstimatedFairValue	2576009000	usd
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1273615000	usd
CY2024Q3	zs	Cash Equivalents Gross Unrealized Gains CashEquivalentsGrossUnrealizedGains	0	usd
CY2024Q3	zs	Cash Equivalents Gross Unrealized Losses CashEquivalentsGrossUnrealizedLosses	21000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1273594000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	987004000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1565000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1995000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	986574000	usd
CY2024Q3	zs	Cash Equivalents And Available For Sale Securities At Cost CashEquivalentsAndAvailableForSaleSecuritiesAtCost	2260619000	usd
CY2024Q3	zs	Cash Equivalents And Short Term Investments Gross Unrealized Gains CashEquivalentsAndShortTermInvestmentsGrossUnrealizedGains	1565000	usd
CY2024Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	562736000	usd
CY2024Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	562907000	usd
CY2024Q4	zs	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	590915000	usd
CY2024Q4	zs	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	591345000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	1153651000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	1154252000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	439952000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1660000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	36480000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	54000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	476432000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1714000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	299157000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	245000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	247808000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1750000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	546965000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1995000	usd
CY2024Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	12600000	usd
CY2024Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	10700000	usd
CY2024Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	10300000	usd
CY2024Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	9800000	usd
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152557000	shares
CY2024Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001713683
CY2024Q4	dei	Document Period End Date DocumentPeriodEndDate	2024-10-31
CY2024Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q4	dei	Entity Registrant Name EntityRegistrantName	ZSCALER, INC.
CY2024Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1173892
CY2024Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	120 Holger Way
CY2024Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
CY2024Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q4	dei	City Area Code CityAreaCode	408
CY2024Q4	dei	Local Phone Number LocalPhoneNumber	533-0288
CY2024Q4	dei	Security12b Title Security12bTitle	Common Stock, $0.001 Par Value
CY2024Q4	dei	Trading Symbol TradingSymbol	ZS
CY2024Q4	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q4	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024Q4	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1553645000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1423080000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	1154252000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	986574000	usd
CY2024Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424573000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	736529000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	152475000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	148873000	usd
CY2024Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	108835000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	101561000	usd
CY2024Q4	us-gaap	Assets Current AssetsCurrent	3393780000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	3396617000	usd
CY2024Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	409005000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	383121000	usd
CY2024Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84091000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	89758000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	286656000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	296525000	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59595000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	63835000	usd
CY2024Q4	us-gaap	Goodwill Goodwill	417029000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	417029000	usd
CY2024Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	58846000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	58083000	usd
CY2024Q4	us-gaap	Assets Assets	4709002000	usd
CY2024Q3	us-gaap	Assets Assets	4704968000	usd
CY2024Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	25368000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	23309000	usd
CY2024Q4	zs	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	83384000	usd
CY2024Q3	zs	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	91708000	usd
CY2024Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	126379000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	160810000	usd
CY2024Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1533080000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1643919000	usd
CY2024Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	250640000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	251055000	usd
CY2024Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	41938000	usd
CY2024Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24269000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	22100000	usd
CY2024Q4	us-gaap	Liabilities Liabilities	3280457000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	3430866000	usd
CY2024Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	154254000	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	113539000	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50716000	usd
CY2024Q4	us-gaap	Net Income Loss NetIncomeLoss	-12051000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	807525000	usd
CY2024Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q4	dei	Amendment Flag AmendmentFlag	false
CY2024Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95134
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	153438623	shares
CY2024Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1145799000	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1142275000	usd
CY2024Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	49600000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	50866000	usd
CY2024Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2963610000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3112887000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	44824000	usd
CY2024Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	153415000	shares
CY2024Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	153415000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	152490000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	152490000	shares
CY2024Q4	us-gaap	Common Stock Value CommonStockValue	153000	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	152000	usd
CY2024Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2593010000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2426819000	usd
CY2024Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4487000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4789000	usd
CY2024Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1160131000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1148080000	usd
CY2024Q4	us-gaap	Stockholders Equity StockholdersEquity	1428545000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1274102000	usd
CY2024Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4709002000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4704968000	usd
CY2024Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627955000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	496703000	usd
CY2024Q4	us-gaap	Cost Of Revenue CostOfRevenue	141462000	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	111394000	usd
CY2024Q4	us-gaap	Gross Profit GrossProfit	486493000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	385309000	usd
CY2024Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	306087000	usd
CY2023Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	267111000	usd
CY2024Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	56819000	usd
CY2024Q4	us-gaap	Operating Expenses OperatingExpenses	517160000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	431366000	usd
CY2024Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-30667000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-46057000	usd
CY2024Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	30048000	usd
CY2023Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	25942000	usd
CY2024Q4	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3143000	usd
CY2023Q4	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3159000	usd
CY2024Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-652000	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1212000	usd
CY2024Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4414000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24486000	usd
CY2024Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7637000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8997000	usd
CY2024Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2024Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2024Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152557000	shares
CY2024Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152557000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147625000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147625000	shares
CY2024Q4	us-gaap	Net Income Loss NetIncomeLoss	-12051000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-33483000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1041000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-589000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	469000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-15136000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1208000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	654000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-739000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-15790000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	302000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-16379000	usd
CY2024Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11749000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49862000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1274102000	usd
CY2024Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	890000	usd
CY2024Q4	zs	Stock Vested During Period Value StockVestedDuringPeriodValue	0	usd
CY2024Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	165302000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	302000	usd
CY2024Q4	us-gaap	Stockholders Equity StockholdersEquity	1428545000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	725112000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1256000	usd
CY2023Q4	zs	Stock Vested During Period Value StockVestedDuringPeriodValue	0	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	131019000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-16379000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-33483000	usd
CY2024Q4	us-gaap	Net Income Loss NetIncomeLoss	-12051000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-33483000	usd
CY2024Q4	zs	Depreciation Depletion And Amortization Excluding Amortization Of Deferred Contract Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDeferredContractCosts	21423000	usd
CY2023Q4	zs	Depreciation Depletion And Amortization Excluding Amortization Of Deferred Contract Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDeferredContractCosts	13962000	usd
CY2024Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4240000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3036000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	39068000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	30111000	usd
CY2024Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	981000	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	977000	usd
CY2024Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	15657000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	9903000	usd
CY2024Q4	us-gaap	Share Based Compensation ShareBasedCompensation	157178000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	129138000	usd
CY2024Q4	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	5003000	usd
CY2023Q4	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	3199000	usd
CY2024Q4	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-3689000	usd
CY2023Q4	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1564000	usd
CY2024Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-186000	usd
CY2023Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	43000	usd
CY2024Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-644000	usd
CY2023Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1031000	usd
CY2024Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-311975000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-215082000	usd
CY2024Q4	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	32801000	usd
CY2023Q4	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	27680000	usd
CY2024Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8767000	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1349000	usd
CY2024Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1043000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4596000	usd
CY2024Q4	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-6240000	usd
CY2023Q4	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4859000	usd
CY2024Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-34431000	usd
CY2023Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-39232000	usd
CY2024Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-111254000	usd
CY2023Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-40154000	usd
CY2024Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	14202000	usd
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	11011000	usd
CY2024Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	331335000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	260806000	usd
CY2024Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17025000	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28659000	usd
CY2024Q4	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	22429000	usd
CY2023Q4	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	7429000	usd
CY2024Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4377000	usd
CY2024Q4	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	561000	usd
CY2023Q4	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	usd
CY2024Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	430296000	usd
CY2023Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	375929000	usd
CY2024Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	268651000	usd
CY2023Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	253849000	usd
CY2024Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-201660000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-162545000	usd
CY2024Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	890000	usd
CY2023Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1256000	usd
CY2024Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	890000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1256000	usd
CY2024Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	130565000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	99517000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1423080000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1262206000	usd
CY2024Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1553645000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1361723000	usd
CY2024Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9399000	usd
CY2023Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5286000	usd
CY2024Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8894000	usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15617000	usd
CY2024Q4	zs	Net Change In Capital Expenditures Included In Liabilities NetChangeInCapitalExpendituresIncludedInLiabilities	462000	usd
CY2023Q4	zs	Net Change In Capital Expenditures Included In Liabilities NetChangeInCapitalExpendituresIncludedInLiabilities	489000	usd
CY2024Q4	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:144%">Use of Estimates </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:25pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal-use software, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Due to uncertainty in the macroeconomic and geopolitical environment, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.</span></div>
CY2024Q4	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:144%">Fiscal Year </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Our fiscal year ends on July 31. References to fiscal 2025, for example, refer to our fiscal year ending July 31, 2025.</span></div>
CY2024Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1783700000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1895000000	usd
CY2024Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	595200000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	462900000	usd
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4410600000	usd
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.49
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.93
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3Y
CY2024Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	445398000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	375234000	usd
CY2024Q4	zs	Capitalization Of Contract Acquisition Costs CapitalizationOfContractAcquisitionCosts	32801000	usd
CY2023Q4	zs	Capitalization Of Contract Acquisition Costs CapitalizationOfContractAcquisitionCosts	27680000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	39068000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	30111000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	439131000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	372803000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	152475000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	148873000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	286656000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	296525000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	439131000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	445398000	usd
CY2024Q3	zs	Cash Equivalents And Short Term Investments Gross Unrealized Losses CashEquivalentsAndShortTermInvestmentsGrossUnrealizedLosses	2016000	usd
CY2024Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	683712000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	633432000	usd
CY2024Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	274707000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	250311000	usd
CY2024Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	409005000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	383121000	usd
CY2024Q4	zs	Depreciation Depletion And Amortization Excluding Amortization Of Deferred Contract Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDeferredContractCosts	21400000	usd
CY2023Q4	zs	Depreciation Depletion And Amortization Excluding Amortization Of Deferred Contract Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDeferredContractCosts	14000000.0	usd
CY2024Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	22045000	usd
CY2024Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	51371000	usd
CY2024Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	33372000	usd
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	53452000	usd
CY2024Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	47924000	usd
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	47184000	usd
CY2024Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	23038000	usd
CY2024Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	8803000	usd
CY2024Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	126379000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	160810000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	417000000.0	usd
CY2024Q4	us-gaap	Goodwill Goodwill	417000000.0	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	109616000	usd
CY2024Q4	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	109616000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	45781000	usd
CY2024Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4240000	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	50021000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	63835000	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59595000	usd
CY2024Q4	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2024Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4200000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000000.0	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	12545000	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	15772000	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	12948000	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	11115000	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7215000	usd
CY2024Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59595000	usd
CY2024Q4	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	2700000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	469000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-15136000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1208000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	654000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1208000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	654000	usd
CY2024Q4	us-gaap	Hedged Liability Fair Value Hedge Cumulative Increase Decrease HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease	-1500000	usd
CY2024Q3	us-gaap	Hedged Liability Fair Value Hedge Cumulative Increase Decrease HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease	-4100000	usd
CY2020Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1130500000	usd
CY2024Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1149954000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1149954000	usd
CY2024Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2633000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3614000	usd
CY2024Q4	us-gaap	Hedged Liability Fair Value Hedge Cumulative Increase Decrease HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease	-1522000	usd
CY2024Q3	us-gaap	Hedged Liability Fair Value Hedge Cumulative Increase Decrease HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease	-4065000	usd
CY2024Q4	us-gaap	Long Term Debt LongTermDebt	1145799000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	1142275000	usd
CY2024Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	359000	usd
CY2023Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	359000	usd
CY2024Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	981000	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	977000	usd
CY2024Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	1340000	usd
CY2023Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	1336000	usd
CY2024Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1459800000	usd
CY2024Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1465500000	usd
CY2020Q2	us-gaap	Option Indexed To Issuers Equity Strike Price1 OptionIndexedToIssuersEquityStrikePrice1	150.80
CY2020Q2	zs	Option Indexed To Issuers Equity Cap Price OptionIndexedToIssuersEquityCapPrice	246.76
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	453000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.72
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y6M
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	60923000	usd
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	87000	shares
CY2024Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.19
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	14330000	usd
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	366000	shares
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	55.46
CY2024Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	46604000	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	367000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.84
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	59989000	usd
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	283000	shares
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	19.11
CY2024Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y10M24D
CY2024Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	45707000	usd
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	14300000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	23200000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	157178000	usd
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	129138000	usd
CY2024Q4	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	12400000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4700000	usd
CY2024Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7600000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000000.0	usd
CY2024Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12051000	usd
CY2024Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12051000	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-33483000	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33483000	usd
CY2024Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152557000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147625000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147625000	shares
CY2024Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2024Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20619000	shares
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20141000	shares
CY2024Q4	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	7600000	shares
CY2024Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001713683-24-000150-index-headers.html	Edgar Link	pending
0001713683-24-000150-index.html	Edgar Link	pending
0001713683-24-000150.txt	Edgar Link	pending
0001713683-24-000150-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zs-20241031.htm	Edgar Link	pending
zs-20241031.xsd	Edgar Link	pending
zsexhibit311q1fy2510q.htm	Edgar Link	pending
zsexhibit312q1fy2510q.htm	Edgar Link	pending
zsexhibit321q1fy2510q.htm	Edgar Link	pending
zs-20241031_def.xml	Edgar Link	unprocessable
zs-20241031_cal.xml	Edgar Link	unprocessable
zs-20241031_pre.xml	Edgar Link	unprocessable
zs-20241031_lab.xml	Edgar Link	unprocessable
zs-20241031_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZS
Zscaler, Inc. Stock $zs

2024 Q4 Form 10-Q Financial Statement

#000171368324000150 Filed on December 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZS Zscaler, Inc. Stock $zs

2024 Q4 Form 10-Q Financial Statement

#000171368324000150 Filed on December 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZS
Zscaler, Inc. Stock $zs